RANI
Rani Therapeutics·NASDAQ
--
--(--)
--
--(--)
2.42 / 10
Underperform
Fundamental analysis reveals subpar metrics: Days Sales Outstanding at 72.5 days (Group 3, score 0) and Interest Coverage Ratio at 15.5 (Group 1, score 2) underscore liquidity and leverage concerns. Revenue growth is strong YoY, but this is counterbalanced by negative Profit-MV and Cash-MV scores, while PB-ROE remains elevated (Group 4, score 0). The composite fundamental score of 2.4/10 aligns with an Underperform rating.
Analysis Checks(6/10)
Revenue-MV
Value-0.26
Score1/3
Weight12.21%
1M Return4.24%
Value-0.26
Score1/3
Weight12.21%
1M Return4.24%
Days sales outstanding
Value72.55
Score0/3
Weight-10.75%
1M Return-5.18%
Value72.55
Score0/3
Weight-10.75%
1M Return-5.18%
Net income-Revenue
Value-0.17
Score2/3
Weight24.28%
1M Return8.45%
Value-0.17
Score2/3
Weight24.28%
1M Return8.45%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-2.43%
1M Return-1.11%
Value15.48
Score2/3
Weight-2.43%
1M Return-1.11%
Asset-MV
Value-0.50
Score1/3
Weight17.75%
1M Return6.68%
Value-0.50
Score1/3
Weight17.75%
1M Return6.68%
Total operating revenue (YoY growth rate %)
Value78.47
Score2/3
Weight2.60%
1M Return1.11%
Value78.47
Score2/3
Weight2.60%
1M Return1.11%
Profit-MV
Value0.46
Score2/3
Weight24.25%
1M Return8.45%
Value0.46
Score2/3
Weight24.25%
1M Return8.45%
PB-ROE
Value1.80
Score0/3
Weight7.24%
1M Return2.72%
Value1.80
Score0/3
Weight7.24%
1M Return2.72%
Operating revenue (YoY growth rate %)
Value92.66
Score2/3
Weight1.00%
1M Return0.43%
Value92.66
Score2/3
Weight1.00%
1M Return0.43%
Cash-MV
Value-0.07
Score2/3
Weight23.85%
1M Return8.41%
Value-0.07
Score2/3
Weight23.85%
1M Return8.41%
Revenue-MV
Value-0.26
Score1/3
Weight12.21%
1M Return4.24%
Value-0.26
Score1/3
Weight12.21%
1M Return4.24%
Total operating revenue (YoY growth rate %)
Value78.47
Score2/3
Weight2.60%
1M Return1.11%
Value78.47
Score2/3
Weight2.60%
1M Return1.11%
Days sales outstanding
Value72.55
Score0/3
Weight-10.75%
1M Return-5.18%
Value72.55
Score0/3
Weight-10.75%
1M Return-5.18%
Profit-MV
Value0.46
Score2/3
Weight24.25%
1M Return8.45%
Value0.46
Score2/3
Weight24.25%
1M Return8.45%
Net income-Revenue
Value-0.17
Score2/3
Weight24.28%
1M Return8.45%
Value-0.17
Score2/3
Weight24.28%
1M Return8.45%
PB-ROE
Value1.80
Score0/3
Weight7.24%
1M Return2.72%
Value1.80
Score0/3
Weight7.24%
1M Return2.72%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-2.43%
1M Return-1.11%
Value15.48
Score2/3
Weight-2.43%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value92.66
Score2/3
Weight1.00%
1M Return0.43%
Value92.66
Score2/3
Weight1.00%
1M Return0.43%
Asset-MV
Value-0.50
Score1/3
Weight17.75%
1M Return6.68%
Value-0.50
Score1/3
Weight17.75%
1M Return6.68%
Cash-MV
Value-0.07
Score2/3
Weight23.85%
1M Return8.41%
Value-0.07
Score2/3
Weight23.85%
1M Return8.41%
Is RANI fundamentally strong?
- RANI scores 2.42/10 on fundamentals and holds a Premium valuation at present. Backed by its 0.00% ROE, 0.00% net margin, -5.24 P/E ratio, -12.38 P/B ratio, and 26.67% earnings growth, these metrics solidify its Underperform investment rating.
